QSAM Biosciences EBITDA
Cos'è EBITDA di QSAM Biosciences?
EBITDA di QSAM Biosciences, Inc. è -$1.30
Qual è la definizione di EBITDA?
L'EBITDA è il reddito di una società prima di interessi, imposte, deprezzamenti e ammortamenti ed è una misura contabile calcolata utilizzando gli utili netti di una società, prima che vengano sottratti interessi passivi, imposte, ammortamenti e ammortamenti come proxy della redditività corrente di un'azienda.
Although EBITDA is not a financial measure recognized in generally accepted accounting principles, it is widely used in many areas of finance when assessing the performance of a company, such as securities analysis. It is intended to allow a comparison of profitability between different companies, by discounting the effects of interest payments from different forms of financing (by ignoring interest payments), political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill). EBITDA is a financial measurement of cash flow from operations that is widely used in mergers and acquisitions of small businesses and businesses in the middle market. It is not unusual for adjustments to be made to EBITDA to normalize the measurement allowing buyers to compare the performance of one business to another.
EBITDA di aziende nel Health Care settore su OTC rispetto a QSAM Biosciences
Cosa fa QSAM Biosciences?
QSAM Biosciences, Inc., a clinical stage biotechnology company, develops drugs for the treatment of bone cancer. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage novel radiopharmaceutical for the treatment of bone cancer and related diseases. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc. and changed its name to QSAM Biosciences, Inc. in September 2020. QSAM Biosciences, Inc. was founded in 2004 and is based in Austin, Texas.
Aziende con ebitda simili a QSAM Biosciences
- Save Foods ha EBITDA di -$1.30
- Transatlantic Mining ha EBITDA di -CAD$1.30
- Ascent Resources plc ha EBITDA di -£1.30
- Tie Kinetix ha EBITDA di -€1.30
- TIE Kinetix N.V ha EBITDA di -€1.30
- Resonate Blends ha EBITDA di -$1.30
- QSAM Biosciences ha EBITDA di -$1.30
- Renascor Resources ha EBITDA di -AUD$1.30
- Kilitch Drugs (India) ha EBITDA di -₨1.30
- Providence Resources Plc ha EBITDA di -€1.30
- Providence Resources P.l.c ha EBITDA di -€1.30
- TriStar Gold ha EBITDA di -$1.30
- Radius Gold ha EBITDA di -CAD$1.30